Table 4 Clinical Outcomes of Patients with Successful CTO-PCI
| Â | No Diabetes | Diabetes | p Value |
|---|---|---|---|
1Â month follow-up | 623 | 331 | Â |
MACE, n% | 54(8.67) | 38(11.48) | 0.161 |
All-cause mortality, n% | 13(2.09) | 9(2.72) | 0.536 |
Nonfatal MI, n% | 6(0.96) | 3(0.91) | 0.931 |
Clinically driven revascularization, n% | 39(6.26) | 29(8.76) | 0.153 |
1Â year follow-up | 584 | 300 | Â |
MACE, n% | 78(13.36) | 53(17.76) | 0.088 |
All-cause mortality, n% | 27(4.62) | 20(6.67) | 0.200 |
Nonfatal MI, n% | 13(2.23) | 6(2.00) | 0.826 |
Clinically driven revascularization, n% | 50(8.56) | 36(12.00) | 0.102 |